Kei Ohnuma

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.

IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.

Journal: Nature communications
Published: January 29, 2026

Hematopoietic dipeptidyl peptidase-4 deficiency promotes M2 macrophage polarization and attenuates atherosclerosis.

Hematopoietic dipeptidyl peptidase-4 deficiency promotes M2 macrophage polarization and attenuates atherosclerosis.

Journal: Biochemical and biophysical research communications
Published: November 19, 2025

An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus.

An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus.

Journal: International immunology
Published: June 27, 2024

Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.

Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.

Journal: American journal of physiology. Lung cellular and molecular physiology
Published: March 12, 2024

Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.

Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.

Journal: International journal of molecular sciences
Published: November 24, 2023

Functional roles of CD26/DPP4 in bleomycin-induced pulmonary fibrosis.

Functional roles of CD26/DPP4 in bleomycin-induced pulmonary fibrosis.

Journal: Physiological reports
Published: February 14, 2023

Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.

Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: May 06, 2022

CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions.

CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions.

Journal: Cureus
Published: March 29, 2021

IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells.

IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells.

Journal: Cell death & disease
Published: January 09, 2021

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody.

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody.

Journal: Biomarker research
Published: December 09, 2020

Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV.

Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV.

Journal: The Journal of allergy and clinical immunology
Published: July 22, 2020

Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Journal: mAbs
Published: August 10, 2019
Showing 1-12 of 47

Last Updated: 09/26/2026